Evaluating the Management of Cancer Immunotherapy (CIT): Roundtable Discussion

Evaluating the Management of Cancer Immunotherapy (CIT): Roundtable Discussion

January 07, 2022

In this AJMC® roundtable discussion, oncology health care decision-making experts consider factors that affect the use of cancer immunotherapies (CITs) and discuss approaches for actualizing policies and procedures within community oncology teams.